Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 351

    1.

    Overexpression of Cu2+/Zn2+ superoxide dismutase protects against early diabetic glomerular injury in transgenic mice.

    Craven PA, Melhem MF, Phillips SL, DeRubertis FR.

    Diabetes. 2001 Sep;50(9):2114-25.PMID: 11522679 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Effects of dietary supplementation of alpha-lipoic acid on early glomerular injury in diabetes mellitus.

    Melhem MF, Craven PA, Derubertis FR.

    J Am Soc Nephrol. 2001 Jan;12(1):124-33.PMID: 11134258 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Acceleration of diabetic renal injury in the superoxide dismutase knockout mouse: effects of tempol.

    DeRubertis FR, Craven PA, Melhem MF.

    Metabolism. 2007 Sep;56(9):1256-64.PMID: 17697870 [PubMed - indexed for MEDLINE]Related articles

    4.

    Overexpression of manganese superoxide dismutase suppresses increases in collagen accumulation induced by culture of mesangial cells in high-media glucose.

    Craven PA, Phillips SL, Melhem MF, Liachenko J, DeRubertis FR.

    Metabolism. 2001 Sep;50(9):1043-8.PMID: 11555836 [PubMed - indexed for MEDLINE]Related articles

    5.

    Attenuation of renal injury in db/db mice overexpressing superoxide dismutase: evidence for reduced superoxide-nitric oxide interaction.

    DeRubertis FR, Craven PA, Melhem MF, Salah EM.

    Diabetes. 2004 Mar;53(3):762-8.PMID: 14988262 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Effects of supplementation with vitamin C or E on albuminuria, glomerular TGF-beta, and glomerular size in diabetes.

    Craven PA, DeRubertis FR, Kagan VE, Melhem M, Studer RK.

    J Am Soc Nephrol. 1997 Sep;8(9):1405-14.PMID: 9294832 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Alpha-lipoic acid attenuates hyperglycemia and prevents glomerular mesangial matrix expansion in diabetes.

    Melhem MF, Craven PA, Liachenko J, DeRubertis FR.

    J Am Soc Nephrol. 2002 Jan;13(1):108-16.PMID: 11752027 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Mechanisms through which bradykinin promotes glomerular injury in diabetes.

    Tan Y, Wang B, Keum JS, Jaffa AA.

    Am J Physiol Renal Physiol. 2005 Mar;288(3):F483-92.PMID: 15692059 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Ras modulation of superoxide activates ERK-dependent fibronectin expression in diabetes-induced renal injuries.

    Lin CL, Wang FS, Kuo YR, Huang YT, Huang HC, Sun YC, Kuo YH.

    Kidney Int. 2006 May;69(9):1593-600.PMID: 16572112 [PubMed - indexed for MEDLINE]Related articles

    11.

    p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.

    Wolf G, Schanze A, Stahl RA, Shankland SJ, Amann K.

    Kidney Int. 2005 Oct;68(4):1583-9.PMID: 16164635 [PubMed - indexed for MEDLINE]Related articles

    12.

    Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy.

    Mizuno S, Nakamura T.

    Am J Physiol Renal Physiol. 2004 Jan;286(1):F134-43. Epub 2003 Sep 30.PMID: 14519594 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.

    Lee EA, Seo JY, Jiang Z, Yu MR, Kwon MK, Ha H, Lee HB.

    Kidney Int. 2005 May;67(5):1762-71.PMID: 15840023 [PubMed - indexed for MEDLINE]Related articles

    14.

    Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes.

    Koya D, Haneda M, Nakagawa H, Isshiki K, Sato H, Maeda S, Sugimoto T, Yasuda H, Kashiwagi A, Ways DK, King GL, Kikkawa R.

    FASEB J. 2000 Mar;14(3):439-47.PMID: 10698958 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Effects of candesartan, an angiotensin II type 1 receptor blocker, on diabetic nephropathy in KK/Ta mice.

    Liao J, Kobayashi M, Kanamuru Y, Nakamura S, Makita Y, Funabiki K, Horikoshi S, Tomino Y.

    J Nephrol. 2003 Nov-Dec;16(6):841-9.PMID: 14736011 [PubMed - indexed for MEDLINE]Related articles

    16.

    Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice.

    Ziyadeh FN, Hoffman BB, Han DC, Iglesias-De La Cruz MC, Hong SW, Isono M, Chen S, McGowan TA, Sharma K.

    Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):8015-20.PMID: 10859350 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    F(2)-isoprostanes mediate high glucose-induced TGF-beta synthesis and glomerular proteinuria in experimental type I diabetes.

    Montero A, Munger KA, Khan RZ, Valdivielso JM, Morrow JD, Guasch A, Ziyadeh FN, Badr KF.

    Kidney Int. 2000 Nov;58(5):1963-72.PMID: 11044216 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Overexpression of upstream stimulatory factor 2 accelerates diabetic kidney injury.

    Liu S, Shi L, Wang S.

    Am J Physiol Renal Physiol. 2007 Nov;293(5):F1727-35. Epub 2007 Sep 19.PMID: 17881461 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Beneficial effects of spironolactone on glomerular injury in streptozotocin-induced diabetic rats.

    Yuan J, Jia R, Bao Y.

    J Renin Angiotensin Aldosterone Syst. 2007 Sep;8(3):118-26.PMID: 17907099 [PubMed - indexed for MEDLINE]Related articles

    20.

    Amelioration of diabetic nephropathy in SPARC-null mice.

    Taneda S, Pippin JW, Sage EH, Hudkins KL, Takeuchi Y, Couser WG, Alpers CE.

    J Am Soc Nephrol. 2003 Apr;14(4):968-80.PMID: 12660331 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data